These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28438933)

  • 1. Pyrazinoic Acid Inhibits a Bifunctional Enzyme in Mycobacterium tuberculosis.
    Njire M; Wang N; Wang B; Tan Y; Cai X; Liu Y; Mugweru J; Guo J; Hameed HMA; Tan S; Liu J; Yew WW; Nuermberger E; Lamichhane G; Liu J; Zhang T
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrazinoic Acid Inhibits the Bifunctional Enzyme (Rv2783) in
    He L; Cui P; Shi W; Li Q; Zhang W; Li M; Zhang Y
    Pathogens; 2019 Nov; 8(4):. PubMed ID: 31718097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1.
    Gopal P; Tasneen R; Yee M; Lanoix JP; Sarathy J; Rasic G; Li L; Dartois V; Nuermberger E; Dick T
    ACS Infect Dis; 2017 Jul; 3(7):492-501. PubMed ID: 28271875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Chain Fatty Acyl Coenzyme A Ligase FadD2 Mediates Intrinsic Pyrazinamide Resistance in Mycobacterium tuberculosis.
    Rosen BC; Dillon NA; Peterson ND; Minato Y; Baughn AD
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esters of Pyrazinoic Acid Are Active against Pyrazinamide-Resistant Strains of Mycobacterium tuberculosis and Other Naturally Resistant Mycobacteria In Vitro and Ex Vivo within Macrophages.
    Pires D; Valente E; Simões MF; Carmo N; Testa B; Constantino L; Anes E
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7693-9. PubMed ID: 26438493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide.
    Zhang Y; Scorpio A; Nikaido H; Sun Z
    J Bacteriol; 1999 Apr; 181(7):2044-9. PubMed ID: 10094680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new approach for pyrazinamide susceptibility testing in Mycobacterium tuberculosis.
    Zimic M; Loli S; Gilman RH; Gutierrez A; Fuentes P; Cotrina M; Kirwan D; Sheen P
    Microb Drug Resist; 2012 Aug; 18(4):372-5. PubMed ID: 22372927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pncA gene expression and prediction factors on pyrazinamide resistance in Mycobacterium tuberculosis.
    Sheen P; Lozano K; Gilman RH; Valencia HJ; Loli S; Fuentes P; Grandjean L; Zimic M
    Tuberculosis (Edinb); 2013 Sep; 93(5):515-22. PubMed ID: 23867321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis.
    Zimhony O; Cox JS; Welch JT; Vilchèze C; Jacobs WR
    Nat Med; 2000 Sep; 6(9):1043-7. PubMed ID: 10973326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis.
    Zhang Y; Zhang J; Cui P; Zhang Y; Zhang W
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Novel Mutations in LprG (
    Shi W; Chen J; Zhang S; Zhang W; Zhang Y
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
    Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT
    BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metallochaperones Are Needed for Mycobacterium tuberculosis and Escherichia coli Nicotinamidase-Pyrazinamidase Activity.
    Sheen P; Monsalve A; Campos J; Huerta R; Antiparra R; Arteaga H; Duran P; Bueno C; Kirwan DE; Gilman RH; Zimic M
    J Bacteriol; 2020 Jan; 202(2):. PubMed ID: 31636108
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipophilic pyrazinoic acid amide and ester prodrugs stability, activation and activity against M. tuberculosis.
    Simões MF; Valente E; Gómez MJ; Anes E; Constantino L
    Eur J Pharm Sci; 2009 Jun; 37(3-4):257-63. PubMed ID: 19491013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncoupling Environmental pH and Intrabacterial Acidification from Pyrazinamide Susceptibility in Mycobacterium tuberculosis.
    Peterson ND; Rosen BC; Dillon NA; Baughn AD
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7320-6. PubMed ID: 26369957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance.
    Zimic M; Fuentes P; Gilman RH; Gutiérrez AH; Kirwan D; Sheen P
    Tuberculosis (Edinb); 2012 Jan; 92(1):84-91. PubMed ID: 22004792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of n-propyl pyrazinoate against pyrazinamide-resistant Mycobacterium tuberculosis: investigations into mechanism of action of and mechanism of resistance to pyrazinamide.
    Speirs RJ; Welch JT; Cynamon MH
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1269-71. PubMed ID: 7574514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel inexpensive electrochemical sensor for pyrazinoic acid as a potential tool for the identification of pyrazinamide-resistant
    Rueda D; Furukawa R; Fuentes P; Comina G; Rey De Castro NG; Requena D; Gilman RH; Sheen P; Zimic M
    Int J Mycobacteriol; 2018; 7(3):275-281. PubMed ID: 30198510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria.
    Singh P; Mishra AK; Malonia SK; Chauhan DS; Sharma VD; Venkatesan K; Katoch VM
    J Commun Dis; 2006 Mar; 38(3):288-98. PubMed ID: 17373362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrazinamide triggers degradation of its target aspartate decarboxylase.
    Gopal P; Sarathy JP; Yee M; Ragunathan P; Shin J; Bhushan S; Zhu J; Akopian T; Kandror O; Lim TK; Gengenbacher M; Lin Q; Rubin EJ; Grüber G; Dick T
    Nat Commun; 2020 Apr; 11(1):1661. PubMed ID: 32245967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.